The White House Task Force Holds Press Briefing After FDA Advisory Committee Recommends Pfizer’s Vaccine For Kids

The White House Task Force holds a press briefing following the the Food and Drug Administration’s vaccine advisory committee on Tuesday voting 17-0, with one member abstaining, to recommend the emergency authorization of Pfizer’s coronavirus vaccine for children between the ages of 5 and 11, a crucial step toward the long-awaited approval of a jab for young kids.